Study of B2 glycoprotein I antibodies in hepatitis c seropositive prevalent hemodialysis patients
Shaimaa Zaki Abd El Megied;
Abstract
Although the precise physiological role of B2-GP1 is not known, in vitro studies suggest that it likely functions as a natural anticoagulant. B2-GP1 has been shown to inhibit intrinsic pathway activation and prothrombinase activities on the surface of a
Other data
| Title | Study of B2 glycoprotein I antibodies in hepatitis c seropositive prevalent hemodialysis patients | Other Titles | دراسة الاجسام المضادة للبيتا 2 جليكوبروتين 1 فى مرضى الاستصفاء الدموى المصابين بالالتهاب الكبدى الفيروسى ج | Authors | Shaimaa Zaki Abd El Megied | Keywords | Study of B2 glycoprotein I antibodies in hepatitis c seropositive prevalent hemodialysis patients | Issue Date | 2012 | Description | Although the precise physiological role of B2-GP1 is not known, in vitro studies suggest that it likely functions as a natural anticoagulant. B2-GP1 has been shown to inhibit intrinsic pathway activation and prothrombinase activities on the surface of a |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 109111p5350.pdf | 267.62 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.